Background
==========

We previously reported a dramatic and sustained CD4+ T cell decline (\<80/μl blood) in two SIV+ sooty mangabeys that was associated with a multi-tropic SIV infection (R5/X4/R2) (Milush et al., J Immunol, 2007). These \'\'AIDS defining\'\' CD4+ T cell levels have been maintained for more than eight years in association with low levels of immune activation and no clinical signs of simian AIDS.

Methods
=======

Three additional mangabeys were inoculated with plasma from a CD4-low mangabey and phenotypic/functional changes in multiple immune cell subsets were monitored via flow cytometry. Monocyte TNF-alpha production was assessed following 6-hour *ex vivo*whole blood stimulations with 10 μg/ml LPS. An influenza vaccine was administered during chronic infection and the resulting antibody response was measured via hemagglutination inhibition and microneutralization assays.

Results
=======

By 20 days post passage, all three SIV-positive mangabeys experienced a severe decline of CD4+ T cells in the blood (40--80 cells/μl), lymph nodes, and GALT. Despite global CD4+ T cell depletion, chronic infection was characterized by low levels of immune activation. SIV specific antibodies and CTL were detectable in all CD4-low mangabeys and, notably, all animals mounted a clear neo-response to influenza vaccination. *Ex vivo*LPS stimulation revealed a reduced monocyte TNF-alpha response in SIV-infected mangabeys (approximately 5% of monocytes responding). In contrast, chronically SIV-infected rhesus macaques exhibited a high monocyte TNF-alpha response that was comparable to uninfected controls (approximately 25% of monocytes responding). The reduction of mangabey monocyte TNF-alpha responses occurred early (by 7 days) following SIV infection.

Conclusion
==========

Multi-tropic SIV was passaged to uninfected mangabeys and induced dramatic systemic CD4+ T cell loss without clinical signs of simian AIDS. The suppression of monocyte inflammatory cytokine production (TNF-alpha) may contribute to the maintenance of low immune activation and preserved adaptive immune responses even in the face of dramatic CD4+ T cell depletion.
